Russell Investments Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47,531
| Closed | -$748K | – | 3651 |
|
|
2024
Q1 | $748K | Sell |
47,531
-2,380
| -5% | -$37.4K | ﹤0.01% | 2080 |
|
|
2023
Q4 | $805K | Buy |
49,911
+7,326
| +17% | +$118K | ﹤0.01% | 2052 |
|
|
2023
Q3 | $542K | Sell |
42,585
-274
| -0.6% | -$3.49K | ﹤0.01% | 2203 |
|
|
2023
Q2 | $603K | Buy |
42,859
+355
| +0.8% | +$5K | ﹤0.01% | 2156 |
|
|
2023
Q1 | $657K | Sell |
42,504
-52,064
| -55% | -$804K | ﹤0.01% | 2157 |
|
|
2022
Q4 | $1.55M | Buy |
94,568
+3,814
| +4% | +$62.5K | ﹤0.01% | 1745 |
|
|
2022
Q3 | $1.68M | Buy |
90,754
+14,896
| +20% | +$275K | ﹤0.01% | 1644 |
|
|
2022
Q2 | $996K | Buy |
75,858
+61,351
| +423% | +$806K | ﹤0.01% | 1964 |
|
|
2022
Q1 | $134K | Sell |
14,507
-4,248
| -23% | -$39.2K | ﹤0.01% | 2522 |
|
|
2021
Q4 | $182K | Sell |
18,755
-69,590
| -79% | -$675K | ﹤0.01% | 2742 |
|
|
2021
Q3 | $3M | Sell |
88,345
-18,997
| -18% | -$645K | 0.01% | 1577 |
|
|
2021
Q2 | $3.93M | Buy |
107,342
+33,995
| +46% | +$1.24M | 0.01% | 1500 |
|
|
2021
Q1 | $3.29M | Buy |
73,347
+30,925
| +73% | +$1.39M | 0.01% | 1579 |
|
|
2020
Q4 | $2.42M | Buy |
42,422
+2,181
| +5% | +$124K | ﹤0.01% | 1653 |
|
|
2020
Q3 | $2.06M | Buy |
40,241
+37,346
| +1,290% | +$1.91M | ﹤0.01% | 1668 |
|
|
2020
Q2 | $172K | Buy |
+2,895
| New | +$172K | ﹤0.01% | 2750 |
|
|
2019
Q1 | – | Sell |
-27,318
| Closed | -$574K | – | 3036 |
|
|
2018
Q4 | $574K | Sell |
27,318
-3,336
| -11% | -$70.1K | ﹤0.01% | 2265 |
|
|
2018
Q3 | $1.19M | Sell |
30,654
-13,444
| -30% | -$521K | ﹤0.01% | 2015 |
|
|
2018
Q2 | $1.74M | Hold |
44,098
| – | – | ﹤0.01% | 1836 |
|
|
2018
Q1 | $884K | Buy |
+44,098
| New | +$884K | ﹤0.01% | 2255 |
|